ADV vs REGN · rev $3.57B vs P/E 14, rev $14.34B
Advantage Solutions Inc (ADV) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Advantage Solutions Inc (ADV) is a advertising agencies company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported ADV revenue for 2024-12-31 was $3.57B. Net income was -$324.8M. Revenue was down 8.6% from 2023-12-31 to 2024-12-31. ADV currently screens at market cap $501.5M.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
ADV currently screens at market cap $501.5M. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the ADV and REGN stock pages for the full models.
Not investment advice.